Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID-19 and associated cancers and diseases. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s13577-022-00697-2

PubMed Identifier: 35377105

Publication URI: http://europepmc.org/abstract/MED/35377105

Type: Journal Article/Review

Volume: 35

Parent Publication: Human cell

Issue: 3

ISSN: 0914-7470